The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dreyer Scott since 2019.
This trader's CIK number is 1746251.
At the time of last reporting, Dreyer Scott was the EVP & Chief Commercial Officer of Collegium Pharmaceutical, Inc. (stock ticker symbol COLL).
Also see all insider trading activities at Collegium Pharmaceutical, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | COLL | 0 | $0 | 65,343 | $2,134,477 | 21,250 | $453,474 |
| 2024 | COLL | 0 | $0 | 23,560 | $760,516 | 0 | $0 |
| 2023 | COLL | 0 | $0 | 13,324 | $355,750 | 0 | $0 |
| 2022 | COLL | 0 | $0 | 10,559 | $228,179 | 0 | $0 |
| 2021 | COLL | 0 | $0 | 14,913 | $332,930 | 0 | $0 |
| 2020 | COLL | 0 | $0 | 15,184 | $348,091 | 8,000 | $127,200 |
| 2019 | COLL | 0 | $0 | 2,857 | $35,169 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | COLL | Sale | 16,389 | 38.21 | 626,174 |
| 2025-08-18 | COLL | Option Ex | 16,389 | 21.34 | 349,741 |
| 2025-08-13 | COLL | Option Ex | 4,861 | 21.34 | 103,733 |
| 2025-08-13 | COLL | Sale | 4,861 | 38.03 | 184,883 |
| 2025-03-21 | COLL | Sale | 18,881 | 30.03 | 566,977 |
| 2025-03-20 | COLL | Sale | 1,927 | 30.00 | 57,811 |
| 2025-03-14 | COLL | Sale | 2,255 | 30.00 | 67,661 |
| 2025-03-06 | COLL | Sale | 15,387 | 30.00 | 461,671 |
| 2025-03-06 | COLL | Sale | 3,295 | 30.00 | 98,853 |
| 2025-03-07 | COLL | Sale | 2,348 | 30.00 | 70,447 |
| 2024-01-16 | COLL | Sale | 23,560 | 32.28 | 760,516 |
| 2023-03-01 | COLL | Sale | 13,324 | 26.70 | 355,750 |
| 2022-02-18 | COLL | Sale | 10,559 | 21.61 | 228,179 |
| 2021-12-15 | COLL | Sale | 5,693 | 18.33 | 104,352 |
| 2021-02-11 | COLL | Sale | 7,898 | 25.11 | 198,318 |
| 2021-01-15 | COLL | Sale | 1,322 | 22.89 | 30,260 |
| 2020-07-13 | COLL | Sale | 1,429 | 17.01 | 24,307 |
| 2020-05-18 | COLL | Option Ex | 8,000 | 15.90 | 127,200 |
| 2020-05-18 | COLL | Sale | 8,000 | 24.00 | 192,000 |
| 2020-05-13 | COLL | Sale | 4,434 | 22.61 | 100,252 |
| 2020-01-14 | COLL | Sale | 1,321 | 23.87 | 31,532 |
| 2019-07-11 | COLL | Sale | 2,857 | 12.31 | 35,169 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dreyer Scott (EVP & Chief Commercial Officer of Collegium Pharmaceutical, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.